4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-047353
Chief Financial Officer sold 3,325 shares at $3.47 ($11,538)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alam Kamran Chief Financial Officer | 2022-08-23 | Sale | −3,325 | $3.47 | $11,538 | 266,121 | D |
| Open-market sales · 3,325 sh · avg $3.47 · $11,538 | |||||||
Loading xslF345X03/doc4.xml…